Bosnia and Herzegovina vs Norway: The number of people with susceptibility test result for rifampicin
Bosnia and Herzegovina
97.7
in 2021
Norway
98.57
in 2021
Bosnia and Herzegovina rank
38th
Norway rank
36th
The number of people with susceptibility test result for rifampicin over time
- Bosnia and Herzegovina
- Norway
How they compare
Norway currently reports 98.57 against 97.7 in Bosnia and Herzegovina, a difference of 0.87.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Norway ahead.
Bosnia and Herzegovina ranks 38th and Norway ranks 36th of 146 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.68 | 95.09 | 1.42 | Norway |
| 2020s | 97.68 | 98.68 | 0.9991 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bosnia and Herzegovina or Norway?
- Norway, at 98.57 against 97.7 in Bosnia and Herzegovina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bosnia and Herzegovina and Norway?
- 0.87, with Norway ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Bosnia and Herzegovina and Norway rank globally for the number of people with susceptibility test result for rifampicin?
- Bosnia and Herzegovina ranks 38th and Norway ranks 36th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.